As has been announced, during the visit of our Society's delegation to the President of the Hellenic Republic on 5-10-2017 to offer him the musical album, the President welcomed with great willingness the invitation of the President of our Society K. Chartofylis, to visit Nisyros and participate in the events for the 70 years since the incorporation of the Dodecanese with motherland. In order to comply with the protocol, the mayor was asked and sent immediately the invitation and the visit came true. So, this so important day, for us the Dodecanesian, the President of Republic was neither in Rhodes nor in Kos but in the small Nisyros.
The offer of the Musical Album to His Excellency the President of Hellenic Republic, 5-10-2017
Doxology in the church of Potamitissa Nisyros
Laying down a wreath at hero’s tomb
The Cultural Society of Kalamata, native town of the President of Republic, parades before him. It was a pleasant surprise by the mayor to our high visitor.
The Nisyrian women’s dancing group, dances before the President of the Republic.
Guided tour of the archaeological museum by archaeologist T. Marketou
Announcement of the President to an honorary citizen of Nisyros, by the mayor Mr. Chr. Koroneos
Mr K. Charfofilis, introduces the professor of geology at the University of Athens and our collaborator, Dr. Evi Nomikou, to the President of the Republic. Dr Nomikou guided the President to the volcano and the volcanic museum at the village Nikia.
The president of Republic at the volcano, together with K. Chartofylis, and Dr. Evi Nomikou and the architect Anna-Nektaria Chartofyli, who guided him.
In the church of the Presentation of the Virgin Mary in Nikia, chanting "to ypermacho ...".
Guided tour at the volcanic museum in Nikia by Dr. P. Nomikos.
At the volcanic museum in Nikia.
Friendly discussion between the President and Mr. K. Chartofylsi in Nikia.
Fluconazole 200 mg buy order to treat leukemias, including acute disseminated encephalomyelitis (ADEM) and chronic encephalomyelitis/septic meningitis (CCDM/S). He noted that leukemias in these patients are particularly sensitive to the anti-Leuconazole agent and may require doses as large 750-1,000 mg/day. In the study described here, authors reported that in four out of six children with chronic disseminated encephalomyelitis, patients did not have clinical improvement after being treated with 0.2 mg/day of benzoyl peroxide plus 0.5 mIU per hour of doxycycline plus 0.2 mg/kg body weight per day of metronidazole. In another placebo-controlled study, Dallman reported that in nine children with acute CNS metastases associated Burkholderia cenocepacia, patients did not respond significantly to a 0.5 mg/day dose of the fluconazole tablets to buy antimycotic metronidazole or a 250 mg dose of benzoyl peroxide against C. cenocepacia, Burkholderia pseudotuberculosis, or pseudotuberculosis. Patel and other colleagues described the results of 18 patients with acute disseminated encephalomyelitis treated 1.25 or 2 mg/kg body weight per day of doxycycline. They concluded that 0.25 mg/kg body weight per day of doxycycline reduced clinical outcomes in all cases, including those who improved substantially on a 0.05 mg/kg dose, but did not affect any children who received 1 mg/kg. One patient who responded to this dose of doxycycline developed a relapse their illness, Buy cialis from canada but treatment was continued. In a more recent study, Patel reported that 10 patients with acute disseminated encephalomyelitis who were treated with doxycycline at a dose of Fluconazol 90 Pills $471 - $429 Per pill 2 mg/kg per day demonstrated clinically significant clinical and microbiologic improvement. A total of 18 children were included in this study. Five children experienced significant improvement with the dose of 2 mg/kg. Patel reported clinical improvement in four patients this study, one of whom showed clinical improvement for 48 hours. Molecular mechanism The mechanisms by which benzoyl peroxide exerts its anti-cancer effects remains a complex issue. The exact mechanism(s) by which benzoyl peroxide protects against cancer in vitro and vivo is unknown. Benzoyl peroxide can act as an oxidative scavenger in the cytosol. In vitro studies have been performed with various species of cells, including human and bovine hepatoma cells pancreatic cancer cells. It appears that benzoyl peroxide inhibits tumor cell growth. In a clinical trial conducted at the University of North Carolina in Chapel Hill, four doses of 1 to 2 mg/day 0.2% benzoyl peroxide in the form of a water soluble emulsion was shown to prevent pancreatic tumorigenesis in mice. Because the use of benzoyl peroxide for treatment cancer was first proposed by Dr. W.I. B. Burdey in the late 1920s, many investigations have been performed to determine whether or not benzoyl peroxide is safe and effective when used in human patients. The following table provides a review of the most common adverse reactions and their management. In the table there are no drug-drug interactions and dose-response relationship with benzoyl peroxide an available clinical reference dose. The dosage recommended is based on the clinical Adapalene lotion generic experience with dru